402 related articles for article (PubMed ID: 26773121)
1. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
Tselios K; Gladman DD; Su J; Urowitz MB
J Rheumatol; 2016 Mar; 43(3):552-8. PubMed ID: 26773121
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
Dall'Era M
Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
[TBL] [Abstract][Full Text] [Related]
3. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
Conti F; Ceccarelli F; Perricone C; Massaro L; Cipriano E; Pacucci VA; Truglia S; Miranda F; Morello F; Alessandri C; Spinelli FR; Valesini G
Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
Mak A; Mok CC
Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
[TBL] [Abstract][Full Text] [Related]
8. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Dittrich K; Ross S; Benz K; Amann K; Dötsch J
Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
Kawazoe M; Kaneko K; Yamada Z; Masuoka S; Mizutani S; Yamada S; Shikano K; Sato H; Kaburaki M; Muraoka S; Kawai S; Nanki T
Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
Weng MY; Weng CT; Liu MF
Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
[TBL] [Abstract][Full Text] [Related]
11. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
Sixdorf U; Bauer H; Märker-Hermann E
Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
[TBL] [Abstract][Full Text] [Related]
12. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
Lanata CM; Mahmood T; Fine DM; Petri M
Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
[TBL] [Abstract][Full Text] [Related]
14. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.
Hara R; Miyazawa H; Nishimura K; Momoi T; Nozawa T; Kikuchi M; Sakurai N; Kizawa T; Shimamura S; Yasuda S; Hiromura K; Sada KE; Kawaguchi Y; Tamura N; Takei S; Takasaki Y; Atsumi T; Mori M
Mod Rheumatol; 2015; 25(6):858-64. PubMed ID: 26215483
[TBL] [Abstract][Full Text] [Related]
15. [Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Comment on the use of mycophenolic acid for systemic lupus erythematosus].
Fischer-Betz R; Hiepe F;
Z Rheumatol; 2007 Feb; 66(1):78-82. PubMed ID: 17216418
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
Lourdudoss C; Vollenhoven Rv
Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.
Laskari K; Mavragani CP; Tzioufas AG; Moutsopoulos HM
Arthritis Res Ther; 2010; 12(6):R208. PubMed ID: 21059275
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
Nannini C; Crowson CS; Matteson EL; Moder KG
Lupus; 2009 Apr; 18(5):394-9. PubMed ID: 19318390
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy of mycophenolate mofetil for systemic lupus erythematosus].
Suzuki D; Ogawa N; Sawada J; Kimoto O; Shimoyama K; Hayashi H
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug; 32(4):263-8. PubMed ID: 19721347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]